Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CNVS vs AIMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CNVS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

CNVS Overall Winner 6-Pillar Tally: CNVS 5 – 1 AIMD Matrix Metrics: CNVS 6 – 4 AIMD

As of Nov 20, 2026, Cineverse Corp. (CNVS) is the stronger overall head-to-head candidate over Ainos, Inc. (AIMD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CNVS carries a Unified Composite Score of 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin), whereas AIMD carries 23.4/100 (STRONG SELL) at $1.18 (13.9x Forward P/E, -101210.2% operating margin).

  • Defensive Composite Rating Caution: Although CNVS compares more favorably head-to-head, both CNVS (35.9/100 SELL) and AIMD (23.4/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CNVS vs AIMD
CNVS NASDAQ Head-to-Head Winner
Cineverse Corp. Class A Common Stock
Services-Video Tape Rental
$1.73
-5.46% 1D
Market Cap $49.1M
TTM Revenue $99M
Forward P/E 38.8x
Beta / 30D Vol 1.19β · 110% Vol
Unified Composite Score
35.9 / 100 SELL
Tech 15.0 Fund 36.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.9 · SMA20: $1.70 · SMA50: $1.82
AIMD NASDAQ
Ainos, Inc. Common Stock
Pharmaceutical Preparations
$1.18
+6.31% 1D
Market Cap $8.4M
TTM Revenue $13,600
Forward P/E 13.9x
Beta / 30D Vol 2.03β · 437% Vol
Unified Composite Score
23.4 / 100 STRONG SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 59
RSI-14: 59.3 · SMA20: $0.84 · SMA50: $1.06

6-Pillar Scorecard Institutional Category Breakdown (CNVS 5 – 1 AIMD)

Columns: Metric · CNVS · AIMD
1. Valuation Multiples AIMD
Forward P/E 38.8x 13.9x
Trailing P/E 38.8x 13.9x
PEG Ratio 0.46x 0.93x
EV / Revenue 0.7x N/M
2. Growth & Scale CNVS
Revenue Growth (YoY) +110.0% -96.7%
Earnings Growth (YoY) +21.1% +0.0%
TTM Revenue (USD) $99M $13,600
Market Cap $49.1M $8.4M
3. Profitability & Quality CNVS
Gross Margin 42.7% 78.7%
Operating Margin -12.0% -101210.2%
Net Profit Margin -2.1% 0.0%
Return on Equity (ROE) -4.6% -196.3%
4. Balance Sheet & Cash Flow CNVS
Cash Generation (TTM) -$18M -$4.4M
Cash Flow Margin -17.9% N/A
Net Cash / Leverage $22M Net Debt (0.65x D/E) $11M Net Debt (2.43x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CNVS
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 131.8% (28th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CNVS
OpEx & R&D Intensity 54.7% of Rev ($54M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Entertainment Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CNVS (6) vs AIMD (4)
Institutional Metric CNVS AIMD Criterion Row Edge
Market Capitalization
Scale
$49.1M $8.4M Larger Scale CNVS
Trailing P/E Ratio
Valuation
38.8x 13.9x Lower Multiple AIMD
Forward P/E Ratio
Valuation
38.8x 13.9x Lower Multiple AIMD
Revenue Growth (YoY)
Growth
+110.0% -96.7% Higher Growth CNVS
Operating Margin (TTM)
Profitability
-12.0% -101210.2% Higher Margin CNVS
Net Profit Margin
Profitability
-2.1% 0.0% Higher Margin AIMD
Return on Equity (ROE)
Capital Efficiency
-4.6% -196.3% Higher ROE CNVS
52-Week Range Position
Momentum
16% ($1–$3) 22% ($0–$4) Stronger Trend AIMD
Beta / 30D Volatility
Risk Regime
1.19β · 110% Vol 2.03β · 437% Vol Lower Realized Risk CNVS
Unified Institutional Score
Composite Signal
35.9 / 100 (SELL) 23.4 / 100 (STRONG SELL) Higher Composite CNVS
Trailing 12M Revenue (USD)
Operating Scale
$99M $13,600 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
42.7% 78.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.46x PEG · 0.7x EV/Rev 0.93x PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$18M ($22M Net Debt (0.65x D/E)) -$4.4M ($11M Net Debt (2.43x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AIMD +27.45 pp
CNVS: +12.34% · AIMD: +39.79%
3M Horizon AIMD +16.78 pp
CNVS: -31.89% · AIMD: -15.11%
6M Horizon AIMD +6.51 pp
CNVS: -29.39% · AIMD: -22.88%
1Y Horizon CNVS +9.16 pp
CNVS: -32.42% · AIMD: -41.58%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CNVS Revenue AIMD Revenue CNVS Op. Margin AIMD Op. Margin Margin Leader
FY2019 $50M $0M -10.5% -13472.1% CNVS
FY2020 $0M $0M -310.6% -8696.7% CNVS
FY2021 $0M $0M -2245.5% -650.5% AIMD
FY2022 $60M $0M -1.7% -397.1% CNVS
FY2023 $70M $0M -13.1% -10815.0% CNVS
FY2024 $50M $0M -32.0% -66772.2% CNVS
FY2025 $80M $0M 10.1% -11268.3% CNVS
FY2026 $70M N/A -23.1% N/A CNVS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CNVS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 131.8%
IV Percentile 28th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact CNVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AIMD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AIMD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CNVS Moat Profile Cyclical / Execution-Driven Positioning
Entertainment Operator
Competes within the Entertainment value chain with $49.1M market capitalization and -12.0% operating margin.
OpEx & R&D Reinvestment 54.7% of Rev ($54M)
90D Engineering Disclosures 0 Published
AIMD Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.4M market capitalization and -101210.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CNVS vs AIMD Key Questions & Quantitative Answers

As of Nov 20, 2026, Cineverse Corp. (CNVS) is the stronger overall head-to-head candidate over Ainos, Inc. (AIMD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CNVS carries a Unified Composite Score of 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin), whereas AIMD carries 23.4/100 (STRONG SELL) at $1.18 (13.9x Forward P/E, -101210.2% operating margin). Defensive Composite Rating Caution: Although CNVS compares more favorably head-to-head, both CNVS (35.9/100 SELL) and AIMD (23.4/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

CNVS leads the Growth & Scale pillar: CNVS posts +110.0% YoY revenue growth and +21.1% YoY earnings growth on $99M TTM revenue (42.7% gross margin, -12.0% operating margin), compared with AIMD at -96.7% YoY revenue growth and +0.0% YoY earnings growth on $13,600 TTM revenue (78.7% gross margin, -101210.2% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CNVS cumulative revenue shifted +40.0% while AIMD shifted N/A. In operating R&D and SG&A reinvestment, CNVS deploys 54.7% of Rev ($54M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AIMD.

AIMD screens cheaper on headline valuation multiples. CNVS trades at 38.8x Forward P/E, 38.8x Trailing P/E, 0.46x PEG, and 0.7x EV/Revenue (-17.9% FCF margin), whereas AIMD trades at 13.9x Forward P/E, 13.9x Trailing P/E, 0.93x PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CNVS (-4.6% ROE) versus AIMD (-196.3% ROE) capital efficiency.

In options market volatility and institutional positioning, CNVS carries 131.8% implied volatility (28th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 110% Vol realized risk). By comparison, AIMD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.03β · 437% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.